Grey Cloak Tech Stock Performance
| HYEX Stock | USD 1.44 0.06 4.35% |
The company retains a Market Volatility (i.e., Beta) of 1.12, which attests to a somewhat significant risk relative to the market. Grey Cloak returns are very sensitive to returns on the market. As the market goes up or down, Grey Cloak is expected to follow. At this point, Grey Cloak Tech has a negative expected return of -0.65%. Please make sure to check out Grey Cloak's maximum drawdown, as well as the relationship between the rate of daily change and relative strength index , to decide if Grey Cloak Tech performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Grey Cloak Tech has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain fairly strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
| Begin Period Cash Flow | 59.2 K | |
| Total Cashflows From Investing Activities | -96 K | |
| Free Cash Flow | -997.3 K |
Grey |
Grey Cloak Relative Risk vs. Return Landscape
If you would invest 252.00 in Grey Cloak Tech on December 21, 2024 and sell it today you would lose (108.00) from holding Grey Cloak Tech or give up 42.86% of portfolio value over 90 days. Grey Cloak Tech is currently does not generate positive expected returns and assumes 6.687% risk (volatility on return distribution) over the 90 days horizon. In different words, 59% of otc stocks are less volatile than Grey, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Grey Cloak Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Grey Cloak's investment risk. Standard deviation is the most common way to measure market volatility of otc stocks, such as Grey Cloak Tech, and traders can use it to determine the average amount a Grey Cloak's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0979
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | HYEX |
Estimated Market Risk
| 6.69 actual daily | 59 59% of assets are less volatile |
Expected Return
| -0.65 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.1 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Grey Cloak is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Grey Cloak by adding Grey Cloak to a well-diversified portfolio.
Grey Cloak Fundamentals Growth
Grey OTC Stock prices reflect investors' perceptions of the future prospects and financial health of Grey Cloak, and Grey Cloak fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Grey OTC Stock performance.
| Return On Equity | -0.35 | |||
| Return On Asset | -0.27 | |||
| Profit Margin | (0.23) % | |||
| Operating Margin | (0.63) % | |||
| Current Valuation | 19.5 M | |||
| Shares Outstanding | 345.17 M | |||
| Price To Book | 10.42 X | |||
| Price To Sales | 8.20 X | |||
| Revenue | 1.47 M | |||
| EBITDA | (1.93 M) | |||
| Cash And Equivalents | 159.41 K | |||
| Total Debt | 508.2 K | |||
| Debt To Equity | 0.26 % | |||
| Book Value Per Share | 0.01 X | |||
| Cash Flow From Operations | (901.3 K) | |||
| Earnings Per Share | (0) X | |||
| Total Asset | 3.03 M | |||
About Grey Cloak Performance
Evaluating Grey Cloak's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Grey Cloak has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Grey Cloak has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Healthy Extracts Inc., through its subsidiaries, researches, develops, and markets natural plant-based products in the United States and internationally. Healthy Extracts Inc. was incorporated in 2014 and is based in Littleton, Colorado. Healthy Extracts is traded on OTC Exchange in the United States.Things to note about Grey Cloak Tech performance evaluation
Checking the ongoing alerts about Grey Cloak for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for Grey Cloak Tech help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Grey Cloak Tech generated a negative expected return over the last 90 days | |
| Grey Cloak Tech has high historical volatility and very poor performance | |
| Grey Cloak Tech may become a speculative penny stock | |
| The company reported the previous year's revenue of 1.47 M. Net Loss for the year was (1.99 M) with profit before overhead, payroll, taxes, and interest of 695.08 K. | |
| Grey Cloak Tech currently holds about 159.41 K in cash with (901.3 K) of positive cash flow from operations. | |
| Roughly 52.0% of the company shares are held by company insiders |
- Analyzing Grey Cloak's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Grey Cloak's stock is overvalued or undervalued compared to its peers.
- Examining Grey Cloak's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Grey Cloak's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Grey Cloak's management team can help you assess the OTC Stock's leadership.
- Pay attention to analyst opinions and ratings of Grey Cloak's otc stock. These opinions can provide insight into Grey Cloak's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Grey OTC Stock Analysis
When running Grey Cloak's price analysis, check to measure Grey Cloak's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Grey Cloak is operating at the current time. Most of Grey Cloak's value examination focuses on studying past and present price action to predict the probability of Grey Cloak's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Grey Cloak's price. Additionally, you may evaluate how the addition of Grey Cloak to your portfolios can decrease your overall portfolio volatility.